L'Aquila, Italy

Gabriella Melillo


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriella Melillo: Innovator in Antitussive Agents

Introduction

Gabriella Melillo is a prominent inventor based in L'Aquila, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare solutions.

Latest Patents

Gabriella holds a patent for 1,3-dioxolanes with antitussive activity. This patent, titled "(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals useful as antitussive agents and as intermediates for the preparation of levodropropizine and the salts thereof, as well as a process for the preparation of said acetals," highlights her innovative approach to addressing cough-related ailments. This patent represents a significant advancement in the pharmaceutical industry, with potential benefits for patients suffering from coughs.

Career Highlights

Gabriella is currently employed at Dompé S.p.A., a leading pharmaceutical company known for its commitment to research and development. Her role at the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to innovative healthcare solutions.

Collaborations

Throughout her career, Gabriella has worked alongside notable colleagues, including Marcello Allegretti and Maria Candida Cesta. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of her projects.

Conclusion

Gabriella Melillo's work in the development of antitussive agents exemplifies her commitment to advancing pharmaceutical science. Her patent and collaborations reflect her significant impact on the industry, making her a noteworthy inventor in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…